Abstract
Hemophilia is a chronic genetic disorder characterized by deficiencies in clotting factors, leading to prolonged bleeding episodes. Hemophilia A (Factor VIII deficiency) and Hemophilia B (Factor IX deficiency) are the two most common forms. In regions with limited access to healthcare, such as Kashmir, hemophilia management is challenging, often affecting patients' quality of life (QoL).
References
- Gringeri A, Ewenstein B and Reininger A. “The burden of disease and the benefit of prophylaxis in patients with haemophilia: a clinical and economic review”. Haemophilia 17.6 (2011): 799-808.
- Manco-Johnson MJ., et al. “Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia”. N Engl J Med 357.6 (2007): 535-544.
- Plug I., et al. “Social participation of patients with hemophilia in the Netherlands”. Haemophilia 14.5 (2008): 894-903.
- Poon JL., et al. “Quality of life in hemophilia A: Hemophilia-specific assessment in the Hemophilia Utilization Group Study”. Blood Coagul Fibrinolysis 23.4 (2012): 325-331.